Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ronrydellon Apr 12, 2013 10:18am
286 Views
Post# 21246203

RE: RE: RE: market denied confirmation.

RE: RE: RE: market denied confirmation.

What we now can hope for and what can expect in the next sixty days: 1) if we can hold in the $3.10 to $3.20 range with 50k to 100K shares traded daily it will be a GOOD thing. However 60 days plus is a long time in this business, countered only by the "deadline" of still owning shares, or new investors getting in, by May 28, when shares must be held to qualify for the one to one spinoff,that will create motivation to hold or buy.

I will still be surprised and pleased if we are still at $3.00 as the June 30 timeframe closes in as inactivity and time tends to make people forget.Hopefully I'm dead wrong and we have just the opposite and we're over $4.00. Just IMHO.

Bullboard Posts